C12Y 401/01022
Histidine decarboxylase
Official title: Histidine decarboxylase (4.1.1.22)
C12Y401/01022 (Histidine decarboxylase) appears on 6 US grants and 13 published applications in this corpus.
Search patents in C12Y- Granted patents
- 6
- Published applications
- 13
- Assignees
- 8
- Inventors
- 26
- Latest grant
- 19 Nov 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 1 | 1 |
| 2007 | 0 | 3 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 2 |
| 2021 | 1 | 3 |
| 2022 | 0 | 0 |
| 2023 | 2 | 1 |
| 2024 | 1 | 1 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Mutated histidine decarboxylase and use thereof19 Nov 2024US 12,146,174 B2Ajinomoto Co., Inc.
- Engineered biosynthetic pathways for production of histamine by fermentation29 Aug 2023US 11,739,355 B2Zymergen Inc.
- Mutated histidine decarboxylase and use thereof1 Aug 2023US 11,713,454 B2Ajinomoto Co., Inc.
- PEG-ACS/M-siRNA nanocomposite, application thereof, and method for reducing histamine content during fishmeal storage20 Apr 2021US 10,982,015 B2Rongcheng Huatong Marine Biotechnology Co. LTD
- Animals with high histamine productivity22 Aug 2006US 7,094,947 B2Japan Science and Technology Corporation
- Compositions and methods for the treatment of sepsis13 Aug 2026US 2026/0234635 A1
- Engineered Biosynthetic Pathways for Production of Histamine by Fermentation18 Apr 2024US 2024/0124907 A1Zymergen Inc.
- Mutated histidine decarboxylase and use thereof21 Sep 2023US 2023/0295600 A1Ajinomoto Co., Inc.
- Genetic elements in enterococcus spp. to produce dopamine28 Oct 2021US 2021/0332396 A1Iowa State University Research Foundation, Inc.
- Treatment of cancer by guanidinium derivatives22 Jul 2021US 2021/0220295 A1Ucar Health GmbH
Most cited
By later US patents